Personalised randomised controlled trial designs – a new paradigm to define optimal treatments for carbapenem-resistant infections (Lancet Infectious Diseases, 2021)

(untitled) - Walker, AS; White, IR; Turner, R; Yang, HL; Wen, YT; White, N; Sharland, M; Thwaites, G